Corrigendum to “Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cells” (Biochemical Pharmacology (2015) 93(3) (290–304), (S0006295214006996), (10.1016/j.bcp.2014.12.003))

Martin, S.

Corrigendum to “Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cells” (Biochemical Pharmacology (2015) 93(3) (290–304), (S0006295214006996), (10.1016/j.bcp.2014.12.003))

Martin, S.

biochemical pharmacology 2020 Vol. 175 pp. 0-0

312

martin2020corrigendumbiochemical

Access

DOI:

10.1016/j.bcp.2020.113810

Citation

ID: 100961

Ref Key: martin2020corrigendumbiochemical

Use this key to autocite in SciMatic or Thesis Manager

References

No Bibliography

Blockchain Verification

Account:

NFT Contract Address:

0x95644003c57E6F55A65596E3D9Eac6813e3566dA

Article ID:

100961

Unique Identifier:

10.1016/j.bcp.2020.113810

Network:

Scimatic Chain (ID: 481)

Blockchain Readiness Checklist

Authors

Abstract

Journal Name

Year

Title

4/5

Blockchain Upload Locked

Complete all 5 checklist items to tokenize your article

Gas fees required in SCI Coins

Buy SCI

Saymatik Web3.0 Wallet

Google Play

App Store

Corrigendum to “Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cells” (Biochemical Pharmacology (2015) 93(3) (290–304), (S0006295214006996), (10.1016/j.bcp.2014.12.003))

Access

Citation

References

References

Blockchain Verification

Blockchain Readiness Checklist

Saymatik Web3.0 Wallet

About

Services

Legal

License